142 related articles for article (PubMed ID: 20308269)
1. Cholesterol microembolization syndrome: a complication of anticoagulant therapy.
Varis J; Kuusniemi K; Järveläinen H
CMAJ; 2010 Jun; 182(9):931-3. PubMed ID: 20308269
[No Abstract] [Full Text] [Related]
2. Warfarin-related purple toes syndrome and cholesterol microembolization.
Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol microembolization syndrome.
Kay JM
CMAJ; 2010 Oct; 182(15):1647; author reply 1647. PubMed ID: 20956515
[No Abstract] [Full Text] [Related]
4. Purple toes and livido reticularis in a patient with cardiovascular disease taking coumadin. Cholesterol emboli associated with coumadin therapy.
Park S; Schroeter AL; Park YS; Fortson J
Arch Dermatol; 1993 Jun; 129(6):777, 780. PubMed ID: 8507086
[No Abstract] [Full Text] [Related]
5. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
6. Cholesterol microembolization and stable renal function with continued anticoagulation.
Acker CG
South Med J; 1992 Feb; 85(2):210-2. PubMed ID: 1738893
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulant therapy: a precipitating factor in the pathogenesis of cholesterol embolization?
Nevelsteen A; Kutten M; Lacroix H; Suy R
Acta Chir Belg; 1992; 92(1):33-6. PubMed ID: 1553847
[TBL] [Abstract][Full Text] [Related]
8. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
Talmadge DB; Spyropoulos AC
Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
[TBL] [Abstract][Full Text] [Related]
9. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
[TBL] [Abstract][Full Text] [Related]
10. Unusual side effects due to warfarin.
Krahn MJ; Pettigrew NM; Cuddy TE
Can J Cardiol; 1998 Jan; 14(1):90-3. PubMed ID: 9487280
[TBL] [Abstract][Full Text] [Related]
11. Case report: "purple toes" syndrome: an uncommon complication of oral anticoagulant therapy.
Di Cato MA
Postgrad Med; 1975 Dec; 58(7):133-4. PubMed ID: 1197146
[No Abstract] [Full Text] [Related]
12. Cholesterol crystal embolization caused by anticoagulant therapy.
Cortez AF; Sakuma TH; Lima RB; de Figueiredo WM; Valle Hde A; Tolstoy FA; Coimbra DD; Lupi O
Int J Dermatol; 2009 Sep; 48(9):989-90. PubMed ID: 19702986
[No Abstract] [Full Text] [Related]
13. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
Warkentin TE; Whitlock RP; Teoh KH
Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
[TBL] [Abstract][Full Text] [Related]
14. A case of unilateral purple toes due to warfarin.
Al-Niaimi F; Clark C
Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
[No Abstract] [Full Text] [Related]
15. Ask the doctor. Is warfarin turning my toes purple?
Goldhaber SZ
Harv Heart Lett; 2007 Jul; 17(11):7. PubMed ID: 17694613
[No Abstract] [Full Text] [Related]
16. Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use.
Kano Y; Shigehara Y
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37798039
[No Abstract] [Full Text] [Related]
17. Warfarin induced skin necrosis.
Chan YC; Valenti D; Mansfield AO; Stansby G
Br J Surg; 2000 Mar; 87(3):266-72. PubMed ID: 10718793
[TBL] [Abstract][Full Text] [Related]
18. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
Rindone JP; Mellen CK; Eliason JD
Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
[TBL] [Abstract][Full Text] [Related]
19. An interesting potential reaction to warfarin.
Mc AG; Swinson B
Dent Update; 2012; 39(1):33-4, 37. PubMed ID: 22720378
[TBL] [Abstract][Full Text] [Related]
20. [Thromboembolic complication following temporary discontinuance of anticoagulant therapy in a patient with mechanical heart valve].
Christensen TD; Houlind KC; Klaaborg KE; Kure HH; Eiskjaer H; Hasenkam JM
Ugeskr Laeger; 2003 Jul; 165(28):2823-4. PubMed ID: 12891906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
